BioSpace News Archive

Second Genome announced that the Company will present a demo of Odessa, its proprietary big data analytics software that is foundational to the Company’s multi-disciplinary microbiome discovery and development platform, at the virtual Microbiome Data Congress on June 9–10, 2021.

REGENXBIO Inc. announced it will participate in the following June investor conferences, which will each be held in a virtual meeting format

Virios Therapeutics, Inc., a clinical-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with virally triggered or maintained immune responses, announced that data from the company’s Phase 2a clinical trial PRID-201 demonstrated that IMC-1 was better tolerated than placebo in patients with fibromyalgia.

Generation Bio Co. announced that Geoff McDonough, M.D., president and chief executive officer, will present at the JMP Securities Life Sciences Conference on Wednesday, June 16, at 11:30 a.m. ET.

KemPharm, Inc., a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced its expected addition to the broad-market Russell 3000® Index and the Russell 2000® Index in accordance with the 2021 Russell indexes annual reconstitution.

CDR-Life Inc., a biotherapeutics company developing tumor-specific immunotherapies based on a proprietary antibody platform, announced the expansion of its leadership team with the appointment of Björn Peters as chief business officer.

NeuPath Health Inc., owner and operator of a network of clinics that deliver category-leading treatment for chronic pain, as well as spinal injuries, sports-related injuries, and concussions, announced a strategic transaction to acquire KumoCare, a virtual care platform to further expand NeuPath’s virtual care and telemedicine offerings.

9 Meters Biopharma, Inc. today announced that John Temperato, CEO of 9 Meters Biopharma will deliver a company presentation at 2021 BIO Digital being held June 10-11 & 14-18, 2021.

Hepion Pharmaceuticals, Inc. is pleased to announce that it is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the U.S. market opens on June 28, according to a preliminary list of additions posted June 4.

Datavant and Ciox Health have signed a definitive merger agreement - Combined company positioned to solve the challenge of health data fragmentation.